Early Stage Triple Negative and HER2 Overexpression Breast Cancers Have Similar Survivals in Chinese Patients

Authors

  • Qin Zhang MD,

    1. Cangzhou Central Hospital, Cangzhou, Hebei, China
    Search for more papers by this author
  • Shou-Ching Tang MD, PhD, FACP, FRCPC,

    1. Virginia Piper Cancer Institute, Minneapolis, Minnesota, USA
    Search for more papers by this author
  • Hong Liu MD, PhD

    1. Second Department of Breast Tumor, Department Of Epidemiology, Tianjin Medical University Cancer Institute and Hospital; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education and Key Laboratory of Cancer Prevention; and Therapy, Tianjin, China
    Search for more papers by this author

Address Correspondence and reprint requests to: Hong Liu, MD, PhD, Second Department of Breast Tumor, Tianjin Medical University Cancer Institute and Hospital, Huanhuxi Road, Hexi District, Tianjin, China, 300060, or e-mail: liuh@medmail.com.cn.

No abstract is available for this article.

Ancillary